Skip to content

Clinical trials

Phase 2 Venous Thrombosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thrombosis Phase: Phase 2 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20054
20061
20071
20081
20122
20131
20151
20174
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Utah4
Daiichi Sankyo2
Agen Biomedical1
Bayer1
Bristol-Myers Squibb1
GlaxoSmithKline1
Johns Hopkins All Children's Hospital1
M.D. Anderson Cancer Center1
Mercator MedSystems, Inc.1
National Heart, Lung, and Blood Institute (NHLBI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thrombosis21
Venous Thromboembolism7
Pulmonary Embolism5
Neoplasms3
Thrombosis2
Anemia, Sickle Cell1
Atrial Fibrillation1
COVID-191
Catheter-Related Infections1
Critical Illness1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.